Help Therapeutics is a Nanjing, China-based iPSC therapeutics platform company founded by Dr. Wang Jiaxian that develops cell therapies and operates an authorized iPSC biospecimen bank. The company has multiple R&D pipelines focused on heart failure and tumor immunity. Its iPSC therapy for moderate to severe heart failure has entered large-scale randomized controlled human clinical trials at several authoritative centers nationwide. Help Therapeutics is the first iPSC biospecimen bank authorized by China’s Ministry of Science and Technology and is the only officially recognized iPSC rare disease cell bank named in the National 14th Five-Year Plan. The company supplies diversified biological samples to research institutions and enterprises to accelerate rare disease research and orphan drug development. It plans to advance its independent IP development pipeline and broaden clinical work in the coming year.

Total raised

$25M

Funding rounds

1

Latest round

Series C

Latest activity

Nov 2021